Magnetic nanoparticles: a new tool for antibiotic delivery to sinonasal tissues. Results of preliminary studies


Тип публикации: статья из журнала

Год издания: 2015

Ключевые слова: Nanomedicine, Ferrihydrite nanoparticles, Magnetic field, Antibiotics, Chronic rhinosinusitis

Аннотация: Herein we examined the toxicity, penetration properties and ability of Fe2O3 center dot nH(2)O magnetic nanoparticles extracted from silt of the Borovoye Lake (Krasnoyarsk, Russia) to bind an antibiotic. Experimental studies were carried out using magnetic nanoparticles alone and after antibiotic exposure in tissue samples from nasПоказать полностьюal mucosa, cartilage and bone (in vitro). Toxicity of particles was studied in laboratory animals (in vivo). Tissues removed at endonasal surgery (nasal mucosa, cartilage and bone of the nasal septum) were placed in solution containing nanoparticles and exposed to a magnetic field. Distribution of nanoparticles was determined by Perls' reaction. After intravenous injection, possible toxic effects of injected nanoparticles on the organs and tissues of rats were evaluated by histological examination. Binding between the nanoparticles and antibiotic (amoxicillin clavulanate) was studied using infrared spectroscopy. In 30 in vitro experiments, magnetisation of Fe2O3 center dot nH(2)O nanoparticles resulted in their diffuse infiltration into the mucosa, cartilage and bone tissue of the nose and paranasal sinuses. Intravenous injection of 0.2 ml of magnetic nanoparticles into the rat's tail vein did not result in any changes in parenchymatous organs, and the nanoparticles were completely eliminated from the body within 24 hours. The interaction of nanoparticles with amoxicillin clavulanate was demonstrated by infrared spectroscopy. Positive results of experimental studies provide a basis for further clinical investigations of these magnetic nanoparticles and their use in otorhinolaryngology.

Ссылки на полный текст



Выпуск журнала: Vol. 35, Is. 2

Номера страниц: 97-102

ISSN журнала: 0392100X

Место издания: PISA



  • Dobretsov K. (Siberian Clinical Center FMBA)
  • Lopatin A. (Policlinic №1, Business Administration of the President of Russian Federation)
  • Stolyar S. (Siberian Federal University)